Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms

被引：5
|
作者：
Moia, Riccardo [1 ,2 ]
Cittone, Micol Giulia [2 ,3 ]
Boggione, Paola [1 ,2 ]
Manfredi, Giulia Francesca [2 ,3 ]
Favini, Chiara [1 ,2 ]
Awikeh, Bassel [1 ,2 ]
Pedrinelli, Anita Rebecca [2 ,3 ]
Mahmoud, Abdurraouf Mokhtar [1 ,2 ]
Nicolosi, Maura [1 ,2 ]
Bellan, Mattia [2 ,3 ]
Sainaghi, Pier Paolo [2 ,3 ]
Pirisi, Mario [2 ,3 ]
Gaidano, Gianluca [1 ,2 ]
Patriarca, Andrea [1 ,2 ]
Rigamonti, Cristina [2 ,3 ]
机构：
[1] Univ Piemonte Orientale, Dept Translat Med, Div Hematol, Novara, Italy
[2] Azienda Osped Univ Maggiore Carita, Novara, Italy
[3] Univ Piemonte Orientale, Dept Translat Med, Div Internal Med, Novara, Italy
来源：
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
关键词：
myeloproliferative neoplasms; spleen stiffness; JAK2; mutations; vibration-controlled transient elastography (VCTE); NGS; TRANSIENT ELASTOGRAPHY; PORTAL-HYPERTENSION; STIFFNESS; LIVER;
D O I：
10.3389/fonc.2021.777730
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A total of 63 myeloproliferative neoplasms [MPN; 9 polycythemia vera (PV), 32 essential thrombocythemia (ET), and 22 myelofibrosis (MF)] underwent spleen stiffness (SS) measurement by vibration-controlled transient elastography equipped with a novel spleen-dedicated module. Higher SS values significantly correlated with grade 2-3 bone marrow (BM) fibrosis (p=0.035), with hemoglobin level <10 g/dl (p=0.014) and with white blood cells >= 10,000/mu l (p=0.008). Median SS was significantly higher in MF patients compared to ET and PV (p=0.015). SS also correlated with higher JAK2 variant allele frequency (p=0.02). This study identifies SS as a potential noninvasive tool that reflects BM fibrosis and the mutational burden in MPN.
引用
收藏
页数：5
相关论文
共 50 条
  • [1] STIFFER SPLEEN PREDICTS HIGHER BONE MARROW FIBROSIS AND HIGHER JAK2 ALLELE BURDEN IN PATIENTS WITH MYELOPROLIFERATIVE NEOPLASMS
    Moia, R.
    Boggione, P.
    Cittone, M.
    Manfredi, G.
    Favini, C.
    Awikeh, B.
    Pirisi, M.
    Gaidano, G.
    Patriarca, A.
    Rigamonti, C.
    HAEMATOLOGICA, 2021, 106 (10) : 82 - 83
  • [2] JAK2 ALLELE BURDEN IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
    Napolitano, M.
    Siragusa, S.
    Mancuso, S.
    Santoro, M.
    Cariccio, M. R. Lanza
    Bono, M.
    Di Piazza, F.
    Russo, A.
    Accurso, V.
    HAEMATOLOGICA, 2017, 102 : 811 - 811
  • [3] JAK2 p.V617F detection and allele burden measurement in peripheral blood and bone marrow aspirates in patients with myeloproliferative neoplasms
    Takahashi, Koichi
    Patel, Keyur P.
    Kantarjian, Hagop
    Luthra, Rajyalakshmi
    Pierce, Sherry
    Cortes, Jorge
    Verstovsek, Srdan
    BLOOD, 2013, 122 (23) : 3784 - 3786
  • [4] JAK2 allele burden in the myeloproliferative neoplasms: effects on phenotype, prognosis and change with treatment
    Vannucchi, Alessandro M.
    Pieri, Lisa
    Guglielmelli, Paola
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2011, 2 (01) : 21 - 32
  • [5] Higher JAK2 V617F mutant allele burden in patients with chronic myeloproliferative neoplasms is associated with a higher prevalence of chronic kidney disease and unfavorable dynamics of kidney function over time
    Marko Lucijanic
    Petra Veic
    Ivona Aric
    Katarina Marija Tupek
    Ena Soric
    Anica Sabljic
    Josipa Vlasac Glasnovic
    Tajana Stoos-Veic
    Ivan Krecak
    Rajko Kusec
    Annals of Hematology, 2023, 102 : 1955 - 1956
  • [6] Higher JAK2 V617F mutant allele burden in patients with chronic myeloproliferative neoplasms is associated with a higher prevalence of chronic kidney disease and unfavorable dynamics of kidney function over time
    Lucijanic, Marko
    Veic, Petra
    Aric, Ivona
    Tupek, Katarina Marija
    Soric, Ena
    Sabljic, Anica
    Vlasac Glasnovic, Josipa
    Stoos-Veic, Tajana
    Krecak, Ivan
    Kusec, Rajko
    ANNALS OF HEMATOLOGY, 2023, 102 (07) : 1955 - 1956
  • [7] JAK2V617F allele burden in patients with myeloproliferative neoplasms
    Salem H. Alshemmari
    Reshmi Rajaan
    Reem Ameen
    Mohammad A. Al-Drees
    Marwa R. Almosailleakh
    Annals of Hematology, 2014, 93 : 791 - 796
  • [8] JAK2V617F allele burden in patients with myeloproliferative neoplasms
    Alshemmari, Salem H.
    Rajaan, Reshmi
    Ameen, Reem
    Al-Drees, Mohammad A.
    Almosailleakh, Marwa R.
    ANNALS OF HEMATOLOGY, 2014, 93 (05) : 791 - 796
  • [9] Influence of JAK2 46/1 haplotype in the natural evolution of JAK2V617F allele burden in patients with myeloproliferative neoplasms
    Alvarez-Larran, Alberto
    Angona, Anna
    Martinez-Aviles, Luz
    Bellosillo, Beatriz
    Besses, Carlos
    LEUKEMIA RESEARCH, 2012, 36 (03) : 324 - 326
  • [10] Comparability of JAK2 p.V617F allele burden in peripheral blood and that in bone marrow in patients with suspected myeloproliferative neoplasms: a single-center prospective study
    Lu, Nina
    Ying, Limei
    Zhang, Xiaochang
    Chen, Jianlin
    Ding, Xiaoxiao
    Guo, Yanrong
    Wang, Wenwen
    Chen, Sai
    Xu, Linglong
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (03): : 2084 - 2089
12345